Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
FLGC
Upturn stock ratingUpturn stock rating

Flora Growth Corp (FLGC)

Upturn stock ratingUpturn stock rating
$0.84
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

02/11/2025: FLGC (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type Stock
Historic Profit -95.36%
Avg. Invested days 23
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 1.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 02/11/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 11.66M USD
Price to earnings Ratio -
1Y Target Price 4
Price to earnings Ratio -
1Y Target Price 4
Volume (30-day avg) 254475
Beta 1.99
52 Weeks Range 0.53 - 2.59
Updated Date 04/2/2025
52 Weeks Range 0.53 - 2.59
Updated Date 04/2/2025
Dividends yield (FY) -
Basic EPS (TTM) -1.3

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date 2025-03-25
When -
Estimate -0.11
Actual -0.4247

Profitability

Profit Margin -26.73%
Operating Margin (TTM) -38.75%

Management Effectiveness

Return on Assets (TTM) -33.12%
Return on Equity (TTM) -291.5%

Valuation

Trailing PE -
Forward PE 7.89
Enterprise Value 10542441
Price to Sales(TTM) 0.2
Enterprise Value 10542441
Price to Sales(TTM) 0.2
Enterprise Value to Revenue 0.18
Enterprise Value to EBITDA -1
Shares Outstanding 19435600
Shares Floating 15303100
Shares Outstanding 19435600
Shares Floating 15303100
Percent Insiders 32.91
Percent Institutions 7.6

Analyst Ratings

Rating 4
Target Price 4
Buy 1
Strong Buy 1
Buy 1
Strong Buy 1
Hold 1
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

Flora Growth Corp

stock logo

Company Overview

overview logo History and Background

Flora Growth Corp. was founded in 2019 and is a vertically integrated cannabis company. It focuses on producing cannabis-derived products, leveraging low-cost cultivation in Colombia and distribution in international markets.

business area logo Core Business Areas

  • Flora Beauty: Cosmetics and skincare products infused with cannabis-derived ingredients.
  • Flora Pharma: Medical cannabis products and pharmaceuticals.
  • Commercial Wholesale: Sells bulk cannabis and derivatives to other companies.
  • Food and Beverage: Cannabis-infused foods and beverages.

leadership logo Leadership and Structure

Luis Merchan is the Chairman and CEO. The company has a board of directors and various management teams responsible for different business segments. The structure focuses on vertical integration and international expansion.

Top Products and Market Share

overview logo Key Offerings

  • Mindy Kaling x Costa Brazil Collection: A collaborative line of skincare products infused with natural ingredients. Market share is difficult to ascertain given the limited availability of information. Competitors: Sephora brands, other celebrity skincare collaborations.
  • JustCBD Brand: A line of CBD products including edibles, topicals, and oils. Competition is fierce in the CBD market, with many players like Charlotte's Web, CBDMD and other major brands, Flora Growth share for this is difficult to pinpoint.

Market Dynamics

industry overview logo Industry Overview

The global cannabis market is experiencing rapid growth, driven by increasing legalization and consumer acceptance. It comprises recreational and medicinal cannabis, CBD products, and related services.

Positioning

Flora Growth aims to be a low-cost producer and distributor, leveraging its cultivation operations in Colombia to supply international markets. They have positioned themselves in beauty, pharma, wholesale, and food and beverage to capture the cannabis market

Total Addressable Market (TAM)

The global cannabis market is projected to reach hundreds of billions of dollars by the end of the decade. Flora Growth's positioning allows them to address various segments within this expansive TAM.

Upturn SWOT Analysis

Strengths

  • Low-cost cultivation in Colombia
  • Vertically integrated operations
  • Diversified product portfolio
  • International distribution network

Weaknesses

  • Limited brand recognition
  • Dependence on regulatory changes
  • Negative profitability
  • High operational and capital expenditures

Opportunities

  • Expansion into new international markets
  • Increased demand for cannabis-derived products
  • Strategic acquisitions
  • Product Innovation

Threats

  • Fluctuations in cannabis prices
  • Intense competition
  • Changing regulations
  • Economic downturns

Competitors and Market Share

competitor logo Key Competitors

  • CGC
  • TLRY
  • ACB

Competitive Landscape

Flora Growth's low-cost production could be a competitive advantage, but it faces significant competition from established players with greater brand recognition and market share. Note market share data is difficult to accurately determine given varying definitions of the overall cannabis market and the companies' specific segments of focus.

Major Acquisitions

Just Brands LLC

  • Year: 2022
  • Acquisition Price (USD millions): 30
  • Strategic Rationale: Expanded the company's footprint in the US CBD market through the addition of this established brand. The goal was to accelerate revenue growth and market penetration for its consumer brand division.

Growth Trajectory and Initiatives

Historical Growth: Past growth has been driven by acquisitions and expansion into new markets. However, profitability remains a challenge.

Future Projections: Future growth relies on increased sales and successful integration of acquired assets. Analyst expectations will be needed to be analyzed.

Recent Initiatives: Recent initiatives include expanding product lines and entering new distribution partnerships.

Summary

Flora Growth is trying to establish itself within the booming cannabis market by focusing on low-cost cultivation and global distribution. However, it faces challenges with profitability, fierce competition, and the need for a stronger brand presence. Successful integration of acquired assets and scaling up operations will be critical. Investors should closely monitor regulatory changes and market conditions to assess the company's long-term viability.

Similar Companies

ACBratingrating

Aurora Cannabis Inc

$4.37
Small-Cap Stock
0%
PASS

ACBratingrating

Aurora Cannabis Inc

$4.37
Small-Cap Stock
0%
PASS

CGCratingrating

Canopy Growth Corp

$1.18
Small-Cap Stock
0%
PASS

CGCratingrating

Canopy Growth Corp

$1.18
Small-Cap Stock
0%
PASS

CRONratingrating

Cronos Group Inc

$1.79
Small-Cap Stock
0%
PASS

CRONratingrating

Cronos Group Inc

$1.79
Small-Cap Stock
0%
PASS

TLRYratingrating

Tilray Inc

$0.65
Small-Cap Stock
0%
PASS

TLRYratingrating

Tilray Inc

$0.65
Small-Cap Stock
0%
PASS

Sources and Disclaimers

Data Sources:

  • Company filings
  • Industry reports
  • Financial news sources

Disclaimers:

This analysis is based on publicly available information and does not constitute investment advice. Market conditions and company performance can change rapidly.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Flora Growth Corp

Exchange NASDAQ
Headquaters Fort Lauderdale, FL, United States
IPO Launch date 2021-05-11
CEO & Director Mr. Clifford A. Starke
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Full time employees 64
Full time employees 64

Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products. It also offers food and beverage, nutraceuticals, cannabis accessories and technology, personal care, and wellness; cannabidiol (CBD) derived products, such as gummies, topicals, tinctures, and vape products; cannabis consumption accessories, personal storage, and travel accessories for the vape and dry herbs. In addition, the company manufactures and distributes pharmaceutical goods and medical cannabis products to treat a variety of health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. The company sells its products under the JustCBD, Vessel, and Phatebo brands. Flora Growth Corp. was incorporated in 2019 and is based in Fort Lauderdale, Florida.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​